Measured Glomerular Filtration Rate Does Not Improve Prediction of Mortality by Cystatin C and Creatinine

Overview

Journal Nephrol Dial Transplant

Publisher Oxford University Press

Specialties General Surgery
Nephrology

Date 2017 Mar 25

PMID 28340079

Citations 8

Authors

Per-Ola Sundin

Per Sjostrom

Ian Jones

Lovisa A Olsson

Ruzan Udumyan

Anders Grubb

Veronica Lindstrom

Scott Montgomery

Affiliations

Soon will be listed here.

Abstract

Background: Cystatin C may add explanatory power for associations with mortality in combination with other filtration markers, possibly indicating pathways other than glomerular filtration rate (GFR). However, this has not been firmly established since interpretation of associations independent of measured GFR (mGFR) is limited by potential multicollinearity between markers of GFR. The primary aim of this study was to assess associations between cystatin C and mortality, independent of mGFR. A secondary aim was to evaluate the utility of combining cystatin C and creatinine to predict mortality risk.

Methods: Cox regression was used to assess the associations of cystatin C and creatinine with mortality in 1157 individuals referred for assessment of plasma clearance of iohexol.

Results: Since cystatin C and creatinine are inversely related to mGFR, cystatin C - 1 and creatinine - 1 were used. After adjustment for mGFR, lower cystatin C - 1 (higher cystatin C concentration) and higher creatinine - 1 (lower creatinine concentration) were independently associated with increased mortality. When nested models were compared, avoiding the potential influence of multicollinearity, the independence of the associations was supported. Among models combining the markers of GFR, adjusted for demographic factors and comorbidity, cystatin C - 1 and creatinine - 1 combined explained the largest proportion of variance in associations with mortality risk ( R 2 = 0.61). Addition of mGFR did not improve the model.

Conclusions: Our results suggest that both creatinine and cystatin C have independent associations with mortality not explained entirely by mGFR and that mGFR does not offer a more precise mortality risk assessment than these endogenous filtration markers combined.

Citing Articles

GFR estimated with creatinine rather than cystatin C is more reflective of the true risk of adverse outcomes with low GFR in kidney transplant recipients.

Keddis M, Howard M, Galapia L, Barreto E, Zhang N, Butterfield R Nephrol Dial Transplant. 2023; 38(8):1898-1906.

PMID: 36646435 PMC: 10387404. DOI: 10.1093/ndt/gfad007.

The complexity of kidney disease and diagnosing it - cystatin C, selective glomerular hypofiltration syndromes and proteome regulation.

Malmgren L, Oberg C, den Bakker E, Leion F, Siodmiak J, Akesson A J Intern Med. 2022; 293(3):293-308.

PMID: 36385445 PMC: 10107454. DOI: 10.1111/joim.13589.

Shrunken Pore Syndrome Is Associated with Renal Function Decline in Female Patients with Kidney Diseases.

Wu Z, Wang L, Li Y, Yao Y, Zeng R Biomed Res Int. 2022; 2022:2177991.

PMID: 35845935 PMC: 9283046. DOI: 10.1155/2022/2177991.

Paradoxical mortality of high estimated glomerular filtration rate reversed by 24-h urine creatinine excretion rate adjustment: sarcopenia matters.

Kao P, Yeh H, Hsia Y, Hsiao Y, Wang J, Chang D J Cachexia Sarcopenia Muscle. 2022; 13(3):1704-1716.

PMID: 35253387 PMC: 9178165. DOI: 10.1002/jcsm.12951.

The Shrunken pore syndrome is associated with poor prognosis and lower quality of life in heart failure patients: the HARVEST-Malmö study.

Xhakollari L, Grubb A, Jujic A, Bachus E, Nilsson P, Leosdottir M ESC Heart Fail. 2021; 8(5):3577-3586.

PMID: 34382359 PMC: 8497365. DOI: 10.1002/ehf2.13485.

References

Royston P, Ambler G, Sauerbrei W . The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999; 28(5):964-74. DOI: 10.1093/ije/28.5.964. View

Grubb A . Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1992; 38 Suppl 1:S20-7. View

Knight E, Verhave J, Spiegelman D, Hillege H, de Zeeuw D, Curhan G . Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65(4):1416-21. DOI: 10.1111/j.1523-1755.2004.00517.x. View

Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

Sjostrom P, Tidman M, Jones I . Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest. 2005; 65(2):111-24. DOI: 10.1080/00365510510013523. View

Levey A, Coresh J, Greene T, Marsh J, Stevens L, Kusek J . Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007; 53(4):766-72. DOI: 10.1373/clinchem.2006.077180. View

Tidman M, Sjostrom P, Jones I . A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant. 2007; 23(1):154-60. DOI: 10.1093/ndt/gfm661. View

Sauerbrei W, Royston P, Binder H . Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007; 26(30):5512-28. DOI: 10.1002/sim.3148. View

Sjostrom P, Jones I, Tidman M . Cystatin C as a filtration marker--haemodialysis patients expose its strengths and limitations. Scand J Clin Lab Invest. 2008; 69(1):65-72. DOI: 10.1080/00365510802326469. View

10.

Stevens L, Schmid C, Greene T, Li L, Beck G, Joffe M . Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009; 75(6):652-60. PMC: 4557800. DOI: 10.1038/ki.2008.638. View

11.

Rule A, Bailey K, Schwartz G, Khosla S, Lieske J, Melton 3rd L . For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int. 2009; 75(10):1071-8. PMC: 2681487. DOI: 10.1038/ki.2008.698. View

12.

Levey A, Stevens L, Schmid C, Zhang Y, Castro 3rd A, Feldman H . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. PMC: 2763564. DOI: 10.7326/0003-4819-150-9-200905050-00006. View

13.

Oterdoom L, Gansevoort R, Schouten J, de Jong P, Gans R, Bakker S . Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis. 2009; 207(2):534-40. DOI: 10.1016/j.atherosclerosis.2009.05.010. View

14.

Nyman U, Grubb A, Sterner G, Bjork J . Different equations to combine creatinine and cystatin C to predict GFR. Arithmetic mean of existing equations performs as well as complex combinations. Scand J Clin Lab Invest. 2009; 69(5):619-27. DOI: 10.1080/00365510902946992. View

15.

Stevens L, Levey A . Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009; 20(11):2305-13. DOI: 10.1681/ASN.2009020171. View

16.

Ix J, de Boer I, Wassel C, Criqui M, Shlipak M, Whooley M . Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study. Circulation. 2010; 121(11):1295-303. PMC: 2844485. DOI: 10.1161/CIRCULATIONAHA.109.924266. View

17.

Grubb A, Bjork J, Nyman U, Pollak J, Bengzon J, Ostner G . Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. Scand J Clin Lab Invest. 2011; 71(2):145-9. PMC: 3072693. DOI: 10.3109/00365513.2010.546879. View

18.

Pencina M, DAgostino Sr R, Steyerberg E . Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011; 30(1):11-21. PMC: 3341973. DOI: 10.1002/sim.4085. View

19.

Mathisen U, Melsom T, Ingebretsen O, Jenssen T, Njolstad I, Solbu M . Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol. 2011; 22(5):927-37. PMC: 3083314. DOI: 10.1681/ASN.2010050479. View

20.

Rule A, Lieske J . Cystatin C is more than GFR, and this may be a good thing. J Am Soc Nephrol. 2011; 22(5):795-7. DOI: 10.1681/ASN.2011030288. View